monthly healthcare newsletter - april 2020 a global …€¦ · investor conference event calendar...
TRANSCRIPT
MONTHLY INTELLIGENCE | UPCOMING EVENTS | MEDIA DIRECTORY | CONFERENCES
MONTHLY HEALTHCARE NEWSLETTER - APRIL 2020A GLOBAL LEADER IN STRATEGIC HEALTHCARE COMMUNICATIONSLondon | New York | Boston | San Francisco
VISIT WWWCONSILIUM-COMMSCOM FOR MORE INTEL
It has been an unprecedented past few weeks and the Consilium team has been as busy as ever helping clients communicate during the COVID-19 crisis Coronavirus has undoubtedly changed the way we all work and while itrsquos very true that we have missed face to face interactions with our clients and colleagues the Consilium team has quickly adapted to the ldquonew normalrdquo aided by the smart technology we now have at our disposal to stay connected In many ways embracing video conferencing and virtual meetings has been a great opportunity to get to see our clients and colleagues in a more informal setting ndash as you will see from some of the pictures below
Despite the disruption and the plethora of announcements we have advised on surrounding COVID-19 including delays to preliminary results COVID-19 impact statements and new AGM venues to name but a few we have seen some exceptional transactions from our clients cross the line These include some significant partnering and licensing deals with Oxford Biomedica signing a new Licence and Clinical Supply Agreement with Juno Therapeutics a Bristol-Myers Squibb company worth up to $227 million as well as potential additional royalties Silence Therapeutics signing a $400m collaboration with AstraZeneca to develop new
BUSINESS (NOT QUITE) AS USUAL CONSILIUMrsquoS LIFE IN LOCKDOWN
siRNA-based medicines and Sitryx securing an impressive $880 million drug development deal with Lilly to develop new immunometabolic medicines Fundraisings by our clients have continued including Synairgen which raised pound14m to progress its live COVID-19 clinical trial iTeos which raised a $125m Series B2 round 4BIO Capitalrsquos portfolio company Redpin which raised $15 million and miDiagnostics which raised euro14 million demonstrating that innovative companies can raise money even in these difficult market conditions We also welcomed the news by Gilde Healthcare in Europe which closed a new $450 million venture and growth capital fund and other US funds which have been announcing similar hefty new healthcare funds
These successful transactions and some of the work being undertaken by our clients in response to the COVID-19 crisis mobilising rapidly to investigate new therapies vaccines and rapid diagnostics remind us of some important truths First that our sector is resilient and will continue to function and innovate as we move through the crisis and second that for the time being at least cash remains king to companies and investors Letrsquos hope we are back to the ldquoold normalrdquo soon Thank you to all our clients for your support and to our Consilium teams in Europe and the US for your continued hard work and dedication
If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact admincscconsilium-commscom
THIS MONTHrsquoS MOVERS AND SHAKERS
CONNAUGHT ROOMS WC2B19 NOVEMBER
If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact
admincscconsilium-commscom
ndash Vectura Group appointed Mark Bridgewater as CCO
ndash Achilles Therapeutics appointed Professor Sergio Quezada as CSO and Carsten Boess as Non-Executive Director
ndash Redpin Therapeutics appointed Abhinav Shukla as CTOO
ndash Bone Therapeutics appoints Stefanos Theoharis as CBO
ndash Unity Biotechnology appointed Anirvan Ghosh as CEO
ndash Altavant Sciences appointed Howard Lazarus as CMO
ndash Theramex appointed Robert Stewart as CEO
ndash AB2 Bio appointed Michael Soldan as CEO
ndash Senti Biosciences appointed Jose Iglesias as CMO
ndash Oculis SA appointed Marcia de Souza Lima as CMO
ndash WindMIL Therapeutics appointed Patrick Fabbio as CFO
ndash Celyad appointed Stephen Rubino as CBO ndash Prothena appointed Brandon Smith as CBO
ndash Fujifilm Diosynth Biotechnologies appointed Martin Meeson as CEO
ndash Adaptate Biotherapeutics appointed Mihriban Tuna as CSO
ndash E-Scape Bio appointed Paul Wren as CSO
ndash CureVac appointed Ingmar Hoerr as CEO
ndash Epizyme appointed Jeffery Kutok as CSO
CONSILIUM STAFFS CHARITY INITIATIVES
Consilium is delighted to support Fuel Our Frontline ndash a great initiative launched to help deliver food direct to NHS workers that are on the front line in the battle against COVID-19 With the help of generous donations from the public to the lsquoFuel Our Frontlinersquo crowd funding page the team has delivered food packages to a number of hospitals
ndash Morphic Therapeutic appointed Peter Linde as CMO
ndash RubrYc Therapeutics appointed Ramesh Baliga as CSO
ndash Thrive Earlier Detection appointed Matt Franklin as CMO
ndash Recursion appointed Shafique Virani as Chief Corporate Development Officer
ndash Urovant Sciences appointed Jim Robinson as CEO
ndash Viracta Therapeutics appointed Lisa Rojkjaer as CMO
ndash Epizyme appointed Jeffery Kutok as CSO
ndash Qiagen appointed Thierry Bernard as CEO
ndash Recursion appointed Michael Secora as CFO
ndash KBP Biosciences appointed Nick Hart as CFO
ndash EpimAb Biotherapeutics appointed Xinyi ldquoDavidrdquo Gu as CFO
ndash Medica Group appointed Richard Jones as CFO
ndash Sutura Therapeutics appointed Mark Beards as CEO
ndash e-therapeutics appointed Laura Roca-Alonso as CBO
ndash Pfizer appointed Susan Desmond-Hellmann to its Board of Directors
ndash ObsEva appointed Fabien de Ladonchamps as CFO
ndash Arix Biosciences appointed Naseem Amin as Executive Chairman
MONTHLY INTELLIGENCE
ndash Helen Albert has left Labiotech and is now working as a freelance journalist
ANALYST AND SPECIALIST SALES MOVES ndash Fowey Harvey joined Liberum as Healthcare Analyst
ndash Khaled Habayeb joined Barclays Life Science Equity Capital Markets Group
ndash Luisa Hector and Kerry Holford joined the healthcare team at Berenberg as equity research analysts
ndash James Mainwaring has left Stifel
MEDIA MOVES ndash Carlo Martuscelli has joined Politico as Healthcare Reporter
ndash Mike Ward has left Informa ndash Peter Evans has now become Senior Business Correspondent for the Sunday Times
ndash Liam Kelly has now become Enterprise Correspondent for The Sunday Times
ndash Smitha Mundasad has returned to BBC News as Health Reporter following her maternity leave
HIGHLIGHTED FUNDRAISING ACTIVITY FROM MARCH TO APRIL 2020
COMPANY NAME AMOUNT TYPE OF COUNTRY DATE
PUBLIC COMPANY FINANCINGS
DermTech $65 million Private Placement US 3-Mar-20
Zogenix $2002 million Follow-on US 5-Mar-20
Karyopharm Therapeutics $150 million Follow-on US 5-Mar-20
BridgeBio Pharma $475 million Private Offering US 5-Mar-20
Kala Pharmaceuticals $1262 million Follow-on US 11-Mar-20
LifeSci Acquisition $60 million Upsized IPO US 11-Mar-20
Imara $752 million IPO US 13-Mar-20
Synairgen pound140 million Follow-on UK 26-Mar-20
PRIVATE COMPANY FINANCINGS
Xilio Therapeutics $1005 million Series B US 2-Mar-20
Pliant Therapeutics $100 million Series C US 3-Mar-20
Akouos $105 million Series B US 3-Mar-20
Element Science $1456 million Series C US 3-Mar-20
CICC Capital $2274 million Fund close China 3-Mar-20
Kahr Medical $18 million Private Round Israel 3-Mar-20
Primmune Therapeutics $7 million Seed Funding US 3-Mar-20
Scipio bioscience euro6 million Series A France 3-Mar-20
Amunix Pharmaceuticals $73 million Series A US 4-Mar-20
Cinclus Pharma AG $263 million Private Round Sweden 5-Mar-20
Culture Biosciences $15 million Series A US 5-Mar-20
GenFleet $50 million Series B China 9-Mar-20
Numab Therapeutics $22 million Series B Switzerland 9-Mar-20
Arkin Holdings $140 million Fund close Israel 11-Mar-20
Silverback Therapeutics $785 million Series B US 11-Mar-20
BioSight $19 million Series C Israel 11-Mar-20
BillionToOne $15 million Series A US 11-Mar-20
Harbour BioMed $75 million Series B US 12-Mar-20
Nurix Therapeutics $120 million Private Round US 12-Mar-20
Sigilon Therapeutics $803 million Series B US 17-Mar-20
Tempus $100 million Series G US 17-Mar-20
Circle Pharma $45 million Series B US 17-Mar-20
Exuma Biotech $19 million Series B US 17-Mar-20
Design Therapeutics $45 million Series A US 21-Mar-20
Apexigen $123 million Series C US 24-Mar-20
Asieris Pharmaceuticals undisclosed Series C China 24-Mar-20
FampS Pharmatech Undisclosed Series B China 24-Mar-20
Abbisko Therapeutics $70 million Series C US 25-Mar-20
IASO Biotherapeutics $60 million Series B China 25-Mar-20
Regenacy Pharmaceuticals $30 million Series A US 25-Mar-20
Redpin Therapeutics $155 million Series A US 25-Mar-20
miDiagnostics euro14 million Private Round Belgium 26-Mar-20
ElevateBio $170 million Series B UK 30-Mar-20
iTeos $125 million Series B2 USBelgium 1-Apr-20
Flagship Pioneering $11 billion Fund Close US 2-Apr-20
Source BioCentury
INVESTOR CONFERENCE EVENT CALENDAR
2020
You can view the full 2020 investor conference event calendar here
APRILBioCentury Future Leaders in the Biotech Industry New York (Cancelled) ARM Cell amp Gene Meeting on the Mediterranean Barcelona (Cancelled) Kempen amp Co Life Sciences Conference Amsterdam (Cancelled) BioTrinity 2020 London (28-29 April) - NOW A DIGITAL EVENT
MAY ChinaBio Partnering Forum Suzhou (Cancelled) BioEquity Europe Barcelona (Cancelled) Citi Swiss Healthcare Day Zurich (7 May) - NOW A DIGITAL EVENT
JUNEJefferies Healthcare Conference London (2-4 June) Goldman Sachs 40th Annual Global Healthcare Conference Palos Verdes (9-11 June) Citi 8th Annual European Healthcare Conference London (16-17 June) Preparing for Prime Time Best Practice Workshop for UK Issuers Considering Access to the US Markets London (POSTPONED) Piper Jaffray Heartland Summit Minneapolis (17-18 June) Next Generation CAR amp T Cell Therapies San Francisco (22-24 June) Bryan Garnier amp Co Annual Oncology Day Paris (24-25 June) JP Morgan European Healthcare Conference London (Cancelled)
JULYBiotech CEO Summit Napa Napa (12-15 July)
AUGUSTCanaccord Genuity Annual Growth Conference Boston (12-13 August)
SEPTEMBERRW Baird Healthcare Conference New York (4-5 September)Wells Fargo Securities Healthcare Conference Boston (5-6 September)Citi 15th Annual BioPharma Conference Boston (9-10 September)Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference New York (14-16 September) CAR-TCR Summit Boston 2020 Boston (14-17 September) Cantor Global Healthcare Conference New York (15-17 September)Cell amp Gene Therapy Manufacturing and Commercialization Boston (21-24 September)Boston Biotech Week Boston (21-24 September)Boston BioTech BD Conference Boston (22 September) Annual HealthTech Investment Forum Basel (22 September)Sachs 20th Annual Biotech in Europe Forum Basel (23-24 September) Ladenburg Thalman Healthcare Conference New York (26 September)BAML Global Healthcare Conference London (TBD) Rodman amp Renshaw Annual Global Investment Conference New York (TBD)BioCentury Annual Newsmakers in the Biotech Industry New York (TBD)
OCTOBERLSX World Congress USA Boston (7 October)BIO Investor Forum 2020 San Francisco (13-14 October)ARM Cell amp Gene meeting on the Mesa Carlsbad (14-16 October)BIO-Europe 2020 Hamburg (26-28 October)BIA UK Bioscience Forum London (TBD)Cowen amp Co Annual Therapeutics Conference New York (TBD)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-10 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November)Inveuro$tival Showcase London (16 November)Jefferies Annual Healthcare Conference London (17-19 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (TBD)
COVID-19 updateThe Awards Ceremony has been re-scheduled from Thursday 11 June 2020 to Tuesday 10
November 2020
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
CONSILIUM IS PROUD TO BE A MEMBER OF
If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact admincscconsilium-commscom
THIS MONTHrsquoS MOVERS AND SHAKERS
CONNAUGHT ROOMS WC2B19 NOVEMBER
If you would like to receive our Monday Healthcare Bulletin which summarises all healthcare business news from the weekend please contact
admincscconsilium-commscom
ndash Vectura Group appointed Mark Bridgewater as CCO
ndash Achilles Therapeutics appointed Professor Sergio Quezada as CSO and Carsten Boess as Non-Executive Director
ndash Redpin Therapeutics appointed Abhinav Shukla as CTOO
ndash Bone Therapeutics appoints Stefanos Theoharis as CBO
ndash Unity Biotechnology appointed Anirvan Ghosh as CEO
ndash Altavant Sciences appointed Howard Lazarus as CMO
ndash Theramex appointed Robert Stewart as CEO
ndash AB2 Bio appointed Michael Soldan as CEO
ndash Senti Biosciences appointed Jose Iglesias as CMO
ndash Oculis SA appointed Marcia de Souza Lima as CMO
ndash WindMIL Therapeutics appointed Patrick Fabbio as CFO
ndash Celyad appointed Stephen Rubino as CBO ndash Prothena appointed Brandon Smith as CBO
ndash Fujifilm Diosynth Biotechnologies appointed Martin Meeson as CEO
ndash Adaptate Biotherapeutics appointed Mihriban Tuna as CSO
ndash E-Scape Bio appointed Paul Wren as CSO
ndash CureVac appointed Ingmar Hoerr as CEO
ndash Epizyme appointed Jeffery Kutok as CSO
CONSILIUM STAFFS CHARITY INITIATIVES
Consilium is delighted to support Fuel Our Frontline ndash a great initiative launched to help deliver food direct to NHS workers that are on the front line in the battle against COVID-19 With the help of generous donations from the public to the lsquoFuel Our Frontlinersquo crowd funding page the team has delivered food packages to a number of hospitals
ndash Morphic Therapeutic appointed Peter Linde as CMO
ndash RubrYc Therapeutics appointed Ramesh Baliga as CSO
ndash Thrive Earlier Detection appointed Matt Franklin as CMO
ndash Recursion appointed Shafique Virani as Chief Corporate Development Officer
ndash Urovant Sciences appointed Jim Robinson as CEO
ndash Viracta Therapeutics appointed Lisa Rojkjaer as CMO
ndash Epizyme appointed Jeffery Kutok as CSO
ndash Qiagen appointed Thierry Bernard as CEO
ndash Recursion appointed Michael Secora as CFO
ndash KBP Biosciences appointed Nick Hart as CFO
ndash EpimAb Biotherapeutics appointed Xinyi ldquoDavidrdquo Gu as CFO
ndash Medica Group appointed Richard Jones as CFO
ndash Sutura Therapeutics appointed Mark Beards as CEO
ndash e-therapeutics appointed Laura Roca-Alonso as CBO
ndash Pfizer appointed Susan Desmond-Hellmann to its Board of Directors
ndash ObsEva appointed Fabien de Ladonchamps as CFO
ndash Arix Biosciences appointed Naseem Amin as Executive Chairman
MONTHLY INTELLIGENCE
ndash Helen Albert has left Labiotech and is now working as a freelance journalist
ANALYST AND SPECIALIST SALES MOVES ndash Fowey Harvey joined Liberum as Healthcare Analyst
ndash Khaled Habayeb joined Barclays Life Science Equity Capital Markets Group
ndash Luisa Hector and Kerry Holford joined the healthcare team at Berenberg as equity research analysts
ndash James Mainwaring has left Stifel
MEDIA MOVES ndash Carlo Martuscelli has joined Politico as Healthcare Reporter
ndash Mike Ward has left Informa ndash Peter Evans has now become Senior Business Correspondent for the Sunday Times
ndash Liam Kelly has now become Enterprise Correspondent for The Sunday Times
ndash Smitha Mundasad has returned to BBC News as Health Reporter following her maternity leave
HIGHLIGHTED FUNDRAISING ACTIVITY FROM MARCH TO APRIL 2020
COMPANY NAME AMOUNT TYPE OF COUNTRY DATE
PUBLIC COMPANY FINANCINGS
DermTech $65 million Private Placement US 3-Mar-20
Zogenix $2002 million Follow-on US 5-Mar-20
Karyopharm Therapeutics $150 million Follow-on US 5-Mar-20
BridgeBio Pharma $475 million Private Offering US 5-Mar-20
Kala Pharmaceuticals $1262 million Follow-on US 11-Mar-20
LifeSci Acquisition $60 million Upsized IPO US 11-Mar-20
Imara $752 million IPO US 13-Mar-20
Synairgen pound140 million Follow-on UK 26-Mar-20
PRIVATE COMPANY FINANCINGS
Xilio Therapeutics $1005 million Series B US 2-Mar-20
Pliant Therapeutics $100 million Series C US 3-Mar-20
Akouos $105 million Series B US 3-Mar-20
Element Science $1456 million Series C US 3-Mar-20
CICC Capital $2274 million Fund close China 3-Mar-20
Kahr Medical $18 million Private Round Israel 3-Mar-20
Primmune Therapeutics $7 million Seed Funding US 3-Mar-20
Scipio bioscience euro6 million Series A France 3-Mar-20
Amunix Pharmaceuticals $73 million Series A US 4-Mar-20
Cinclus Pharma AG $263 million Private Round Sweden 5-Mar-20
Culture Biosciences $15 million Series A US 5-Mar-20
GenFleet $50 million Series B China 9-Mar-20
Numab Therapeutics $22 million Series B Switzerland 9-Mar-20
Arkin Holdings $140 million Fund close Israel 11-Mar-20
Silverback Therapeutics $785 million Series B US 11-Mar-20
BioSight $19 million Series C Israel 11-Mar-20
BillionToOne $15 million Series A US 11-Mar-20
Harbour BioMed $75 million Series B US 12-Mar-20
Nurix Therapeutics $120 million Private Round US 12-Mar-20
Sigilon Therapeutics $803 million Series B US 17-Mar-20
Tempus $100 million Series G US 17-Mar-20
Circle Pharma $45 million Series B US 17-Mar-20
Exuma Biotech $19 million Series B US 17-Mar-20
Design Therapeutics $45 million Series A US 21-Mar-20
Apexigen $123 million Series C US 24-Mar-20
Asieris Pharmaceuticals undisclosed Series C China 24-Mar-20
FampS Pharmatech Undisclosed Series B China 24-Mar-20
Abbisko Therapeutics $70 million Series C US 25-Mar-20
IASO Biotherapeutics $60 million Series B China 25-Mar-20
Regenacy Pharmaceuticals $30 million Series A US 25-Mar-20
Redpin Therapeutics $155 million Series A US 25-Mar-20
miDiagnostics euro14 million Private Round Belgium 26-Mar-20
ElevateBio $170 million Series B UK 30-Mar-20
iTeos $125 million Series B2 USBelgium 1-Apr-20
Flagship Pioneering $11 billion Fund Close US 2-Apr-20
Source BioCentury
INVESTOR CONFERENCE EVENT CALENDAR
2020
You can view the full 2020 investor conference event calendar here
APRILBioCentury Future Leaders in the Biotech Industry New York (Cancelled) ARM Cell amp Gene Meeting on the Mediterranean Barcelona (Cancelled) Kempen amp Co Life Sciences Conference Amsterdam (Cancelled) BioTrinity 2020 London (28-29 April) - NOW A DIGITAL EVENT
MAY ChinaBio Partnering Forum Suzhou (Cancelled) BioEquity Europe Barcelona (Cancelled) Citi Swiss Healthcare Day Zurich (7 May) - NOW A DIGITAL EVENT
JUNEJefferies Healthcare Conference London (2-4 June) Goldman Sachs 40th Annual Global Healthcare Conference Palos Verdes (9-11 June) Citi 8th Annual European Healthcare Conference London (16-17 June) Preparing for Prime Time Best Practice Workshop for UK Issuers Considering Access to the US Markets London (POSTPONED) Piper Jaffray Heartland Summit Minneapolis (17-18 June) Next Generation CAR amp T Cell Therapies San Francisco (22-24 June) Bryan Garnier amp Co Annual Oncology Day Paris (24-25 June) JP Morgan European Healthcare Conference London (Cancelled)
JULYBiotech CEO Summit Napa Napa (12-15 July)
AUGUSTCanaccord Genuity Annual Growth Conference Boston (12-13 August)
SEPTEMBERRW Baird Healthcare Conference New York (4-5 September)Wells Fargo Securities Healthcare Conference Boston (5-6 September)Citi 15th Annual BioPharma Conference Boston (9-10 September)Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference New York (14-16 September) CAR-TCR Summit Boston 2020 Boston (14-17 September) Cantor Global Healthcare Conference New York (15-17 September)Cell amp Gene Therapy Manufacturing and Commercialization Boston (21-24 September)Boston Biotech Week Boston (21-24 September)Boston BioTech BD Conference Boston (22 September) Annual HealthTech Investment Forum Basel (22 September)Sachs 20th Annual Biotech in Europe Forum Basel (23-24 September) Ladenburg Thalman Healthcare Conference New York (26 September)BAML Global Healthcare Conference London (TBD) Rodman amp Renshaw Annual Global Investment Conference New York (TBD)BioCentury Annual Newsmakers in the Biotech Industry New York (TBD)
OCTOBERLSX World Congress USA Boston (7 October)BIO Investor Forum 2020 San Francisco (13-14 October)ARM Cell amp Gene meeting on the Mesa Carlsbad (14-16 October)BIO-Europe 2020 Hamburg (26-28 October)BIA UK Bioscience Forum London (TBD)Cowen amp Co Annual Therapeutics Conference New York (TBD)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-10 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November)Inveuro$tival Showcase London (16 November)Jefferies Annual Healthcare Conference London (17-19 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (TBD)
COVID-19 updateThe Awards Ceremony has been re-scheduled from Thursday 11 June 2020 to Tuesday 10
November 2020
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
CONSILIUM IS PROUD TO BE A MEMBER OF
HIGHLIGHTED FUNDRAISING ACTIVITY FROM MARCH TO APRIL 2020
COMPANY NAME AMOUNT TYPE OF COUNTRY DATE
PUBLIC COMPANY FINANCINGS
DermTech $65 million Private Placement US 3-Mar-20
Zogenix $2002 million Follow-on US 5-Mar-20
Karyopharm Therapeutics $150 million Follow-on US 5-Mar-20
BridgeBio Pharma $475 million Private Offering US 5-Mar-20
Kala Pharmaceuticals $1262 million Follow-on US 11-Mar-20
LifeSci Acquisition $60 million Upsized IPO US 11-Mar-20
Imara $752 million IPO US 13-Mar-20
Synairgen pound140 million Follow-on UK 26-Mar-20
PRIVATE COMPANY FINANCINGS
Xilio Therapeutics $1005 million Series B US 2-Mar-20
Pliant Therapeutics $100 million Series C US 3-Mar-20
Akouos $105 million Series B US 3-Mar-20
Element Science $1456 million Series C US 3-Mar-20
CICC Capital $2274 million Fund close China 3-Mar-20
Kahr Medical $18 million Private Round Israel 3-Mar-20
Primmune Therapeutics $7 million Seed Funding US 3-Mar-20
Scipio bioscience euro6 million Series A France 3-Mar-20
Amunix Pharmaceuticals $73 million Series A US 4-Mar-20
Cinclus Pharma AG $263 million Private Round Sweden 5-Mar-20
Culture Biosciences $15 million Series A US 5-Mar-20
GenFleet $50 million Series B China 9-Mar-20
Numab Therapeutics $22 million Series B Switzerland 9-Mar-20
Arkin Holdings $140 million Fund close Israel 11-Mar-20
Silverback Therapeutics $785 million Series B US 11-Mar-20
BioSight $19 million Series C Israel 11-Mar-20
BillionToOne $15 million Series A US 11-Mar-20
Harbour BioMed $75 million Series B US 12-Mar-20
Nurix Therapeutics $120 million Private Round US 12-Mar-20
Sigilon Therapeutics $803 million Series B US 17-Mar-20
Tempus $100 million Series G US 17-Mar-20
Circle Pharma $45 million Series B US 17-Mar-20
Exuma Biotech $19 million Series B US 17-Mar-20
Design Therapeutics $45 million Series A US 21-Mar-20
Apexigen $123 million Series C US 24-Mar-20
Asieris Pharmaceuticals undisclosed Series C China 24-Mar-20
FampS Pharmatech Undisclosed Series B China 24-Mar-20
Abbisko Therapeutics $70 million Series C US 25-Mar-20
IASO Biotherapeutics $60 million Series B China 25-Mar-20
Regenacy Pharmaceuticals $30 million Series A US 25-Mar-20
Redpin Therapeutics $155 million Series A US 25-Mar-20
miDiagnostics euro14 million Private Round Belgium 26-Mar-20
ElevateBio $170 million Series B UK 30-Mar-20
iTeos $125 million Series B2 USBelgium 1-Apr-20
Flagship Pioneering $11 billion Fund Close US 2-Apr-20
Source BioCentury
INVESTOR CONFERENCE EVENT CALENDAR
2020
You can view the full 2020 investor conference event calendar here
APRILBioCentury Future Leaders in the Biotech Industry New York (Cancelled) ARM Cell amp Gene Meeting on the Mediterranean Barcelona (Cancelled) Kempen amp Co Life Sciences Conference Amsterdam (Cancelled) BioTrinity 2020 London (28-29 April) - NOW A DIGITAL EVENT
MAY ChinaBio Partnering Forum Suzhou (Cancelled) BioEquity Europe Barcelona (Cancelled) Citi Swiss Healthcare Day Zurich (7 May) - NOW A DIGITAL EVENT
JUNEJefferies Healthcare Conference London (2-4 June) Goldman Sachs 40th Annual Global Healthcare Conference Palos Verdes (9-11 June) Citi 8th Annual European Healthcare Conference London (16-17 June) Preparing for Prime Time Best Practice Workshop for UK Issuers Considering Access to the US Markets London (POSTPONED) Piper Jaffray Heartland Summit Minneapolis (17-18 June) Next Generation CAR amp T Cell Therapies San Francisco (22-24 June) Bryan Garnier amp Co Annual Oncology Day Paris (24-25 June) JP Morgan European Healthcare Conference London (Cancelled)
JULYBiotech CEO Summit Napa Napa (12-15 July)
AUGUSTCanaccord Genuity Annual Growth Conference Boston (12-13 August)
SEPTEMBERRW Baird Healthcare Conference New York (4-5 September)Wells Fargo Securities Healthcare Conference Boston (5-6 September)Citi 15th Annual BioPharma Conference Boston (9-10 September)Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference New York (14-16 September) CAR-TCR Summit Boston 2020 Boston (14-17 September) Cantor Global Healthcare Conference New York (15-17 September)Cell amp Gene Therapy Manufacturing and Commercialization Boston (21-24 September)Boston Biotech Week Boston (21-24 September)Boston BioTech BD Conference Boston (22 September) Annual HealthTech Investment Forum Basel (22 September)Sachs 20th Annual Biotech in Europe Forum Basel (23-24 September) Ladenburg Thalman Healthcare Conference New York (26 September)BAML Global Healthcare Conference London (TBD) Rodman amp Renshaw Annual Global Investment Conference New York (TBD)BioCentury Annual Newsmakers in the Biotech Industry New York (TBD)
OCTOBERLSX World Congress USA Boston (7 October)BIO Investor Forum 2020 San Francisco (13-14 October)ARM Cell amp Gene meeting on the Mesa Carlsbad (14-16 October)BIO-Europe 2020 Hamburg (26-28 October)BIA UK Bioscience Forum London (TBD)Cowen amp Co Annual Therapeutics Conference New York (TBD)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-10 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November)Inveuro$tival Showcase London (16 November)Jefferies Annual Healthcare Conference London (17-19 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (TBD)
COVID-19 updateThe Awards Ceremony has been re-scheduled from Thursday 11 June 2020 to Tuesday 10
November 2020
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
CONSILIUM IS PROUD TO BE A MEMBER OF
INVESTOR CONFERENCE EVENT CALENDAR
2020
You can view the full 2020 investor conference event calendar here
APRILBioCentury Future Leaders in the Biotech Industry New York (Cancelled) ARM Cell amp Gene Meeting on the Mediterranean Barcelona (Cancelled) Kempen amp Co Life Sciences Conference Amsterdam (Cancelled) BioTrinity 2020 London (28-29 April) - NOW A DIGITAL EVENT
MAY ChinaBio Partnering Forum Suzhou (Cancelled) BioEquity Europe Barcelona (Cancelled) Citi Swiss Healthcare Day Zurich (7 May) - NOW A DIGITAL EVENT
JUNEJefferies Healthcare Conference London (2-4 June) Goldman Sachs 40th Annual Global Healthcare Conference Palos Verdes (9-11 June) Citi 8th Annual European Healthcare Conference London (16-17 June) Preparing for Prime Time Best Practice Workshop for UK Issuers Considering Access to the US Markets London (POSTPONED) Piper Jaffray Heartland Summit Minneapolis (17-18 June) Next Generation CAR amp T Cell Therapies San Francisco (22-24 June) Bryan Garnier amp Co Annual Oncology Day Paris (24-25 June) JP Morgan European Healthcare Conference London (Cancelled)
JULYBiotech CEO Summit Napa Napa (12-15 July)
AUGUSTCanaccord Genuity Annual Growth Conference Boston (12-13 August)
SEPTEMBERRW Baird Healthcare Conference New York (4-5 September)Wells Fargo Securities Healthcare Conference Boston (5-6 September)Citi 15th Annual BioPharma Conference Boston (9-10 September)Goldman Sachs Annual Biotech Symposium London (11 September)Morgan Stanley Global Healthcare Conference New York (14-16 September) CAR-TCR Summit Boston 2020 Boston (14-17 September) Cantor Global Healthcare Conference New York (15-17 September)Cell amp Gene Therapy Manufacturing and Commercialization Boston (21-24 September)Boston Biotech Week Boston (21-24 September)Boston BioTech BD Conference Boston (22 September) Annual HealthTech Investment Forum Basel (22 September)Sachs 20th Annual Biotech in Europe Forum Basel (23-24 September) Ladenburg Thalman Healthcare Conference New York (26 September)BAML Global Healthcare Conference London (TBD) Rodman amp Renshaw Annual Global Investment Conference New York (TBD)BioCentury Annual Newsmakers in the Biotech Industry New York (TBD)
OCTOBERLSX World Congress USA Boston (7 October)BIO Investor Forum 2020 San Francisco (13-14 October)ARM Cell amp Gene meeting on the Mesa Carlsbad (14-16 October)BIO-Europe 2020 Hamburg (26-28 October)BIA UK Bioscience Forum London (TBD)Cowen amp Co Annual Therapeutics Conference New York (TBD)
NOVEMBERFT Global Pharmaceutical and Biotechnology Conference London (9-10 November)Credit Suisse Annual Healthcare Conference Scottsdale (9-11 November)Consilium Strategic Communications Annual Healthcare Conference London (16 November)Inveuro$tival Showcase London (16 November)Jefferies Annual Healthcare Conference London (17-19 November)Bryan Garnier amp Co 2020 Healthcare Conference Paris (TBD)
COVID-19 updateThe Awards Ceremony has been re-scheduled from Thursday 11 June 2020 to Tuesday 10
November 2020
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
CONSILIUM IS PROUD TO BE A MEMBER OF
CONSILIUM STRATEGIC COMMUNICATIONSINTERNATIONAL HEALTHCARE COMMUNICATIONS
Leading international strategic PR and IR advisor
focused on healthcare
Trusted long-term relationships with clients
Boards and advisors
Networked across all critical stakeholders
Europersquos largest specialist team with deep sector
knowledge
Experts across all sub-sectors
of healthcare
41 LOTHBURY | LONDON | EC2R 7HG NEW YORK | BOSTON | SAN FRANCISCO
+44 (0)20 3709 5700 infoconsilium-commscom wwwconsilium-commscom
ConsiliumHC
19 November Connaught Rooms WC2B
CONSILIUM IS PROUD TO BE A MEMBER OF